While the activation of Raf-1 requires a complex series of events, the activation of B-Raf is much simpler to achieve, explaining why B-Raf is a preferred target for mutational activation in human cancers (Mercer and Pritchard, 2003). This evidence concerns the gene BRAF and cancer.